Pharmacy Consulting

Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, retail pharmacy chains, and software companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

News & Events

Tim Kosty to Present at ASAP 2015 Midyear Conference

PHSI President Tim Kosty will be presenting at the American Society for Automation in Pharmacy (ASAP) 2015 Midyear Conference on June 25-27 in Palm Beach, Florida.  Tim will be discussing retail pharmacy clinical services, focusing on the potential clinical services that can be delivered in a retail pharmacy setting and discussing the perspective of the Read More →

ComputerTalk for the Pharmacist March/April 2015

PHSI Consultant Dave Schuetz contributed to the March/April 2015 edition of ComputerTalk for the Pharmacist. In his Viewpoints article, Dave discusses the challenges surrounding e-prescribing of controlled substances and responsibilities that pharmacies have when utilizing the process and pharmacy system.  Click here to read Dave’s article entitled “E-Prescriptions Leading to Uncharted Waters”.

PHSI Newsletter Spring 2015

The 2015 Spring Edition of the PHSI Newsletter is now available to read here. This issue of the newsletter focuses on the newly approved biosimilar drug Zarxio® and discusses the uncertain future of biosimilars, including medical benefit coverage. If you would like to receive the newsletter electronically, click here to sign up for our e-Newsletter Read More →

Latest from the Blog

Biosimilars & Originators – What’s the Link?

CMS issued a new guidance on biosimilar reimbursement. It sounds simple but now the drug compendia must link the biosimilar with the originator or someone else will meet this marketplace need.

Price Changes of Hydrocodone Combination Products

Following a scientific review of hydrocodone combination products that began in 2009, the FDA recommended in December 2013 that the DEA reclassify these as Schedule II Controlled Substances. The DEA ruling was published August 22, 2014 and rescheduling of hydrocodone combination products took effect on October 6, 2014. For retail pharmacists, this is old news. Read More →

Retail Pharmacy Clinical Services – Decision Criteria

Retail pharmacy is innovating by expanding clinical services. To obtain the best results, the clinical service implementation should be thoroughly evaluated. Listed below are suggested questions to use when evaluating the introduction of new retail pharmacy clinical services.   Questions   Is there evidence based studies that estimate the ROI for the provision of the Read More →